☰

Brian P. Danysh, Ph.D. - Publications

Affiliations: 
2010 Department of Biological Sciences University of Delaware, Newark, DE, United States 
Area:
Molecular Biology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Puli OR, Danysh BP, McBeath E, Sinha DK, Hoang NM, Powell RT, Danysh HE, Cabanillas ME, Cote GJ, Hofmann MC. The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer Cells. Neoplasia (New York, N.Y.). 20: 1121-1134. PMID 30265861 DOI: 10.1016/J.Neo.2018.09.003  0.393
2018 Paez-Mayorga J, Chen AL, Kotla S, Tao Y, Abe RJ, He ED, Danysh BP, Hofmann MC, Le NT. Ponatinib Activates an Inflammatory Response in Endothelial Cells via ERK5 SUMOylation. Frontiers in Cardiovascular Medicine. 5: 125. PMID 30238007 DOI: 10.3389/Fcvm.2018.00125  0.355
2016 Danysh BP, Rieger EY, Sinha DK, Evers CV, Cote GJ, Cabanillas ME, Hofmann MC. Long-Term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model. Oncotarget. PMID 27127178 DOI: 10.18632/Oncotarget.9023  0.353
2016 Danysh BP, Cabanillas ME, Hofmann M. Abstract 2933: Long-term BRAF(V600E) inhibition results in a spontaneous KRAS(G12D) mutation and increased epithelial to mesenchymal transition (EMT) in papillary thyroid cancer cells (PTC) Cancer Research. 76: 2933-2933. DOI: 10.1158/1538-7445.Am2016-2933  0.392
2011 Constantinou PE, Danysh BP, Dharmaraj N, Carson DD. Transmembrane mucins as novel therapeutic targets. Expert Review of Endocrinology & Metabolism. 6: 835-848. PMID 22201009 DOI: 10.1586/Eem.11.70  0.34
2011 Danysh BP, Constantinou PE, Lukianova-Hleb E, Broaddus R, Carson DD. Abstract 368: MUC1-targeted gold nanoparticle-based theranostic approach Cancer Research. 71: 368-368. DOI: 10.1158/1538-7445.Am2011-368  0.367
2010 Danysh BP, Patel TP, Czymmek KJ, Edwards DA, Wang L, Pande J, Duncan MK. Characterizing molecular diffusion in the lens capsule. Matrix Biology : Journal of the International Society For Matrix Biology. 29: 228-36. PMID 20026402 DOI: 10.1016/J.Matbio.2009.12.004  0.571
2009 Firtina Z, Danysh BP, Bai X, Gould DB, Kobayashi T, Duncan MK. Abnormal expression of collagen IV in lens activates unfolded protein response resulting in cataract. The Journal of Biological Chemistry. 284: 35872-84. PMID 19858219 DOI: 10.1074/Jbc.M109.060384  0.425
2009 Danysh BP, Duncan MK. The lens capsule. Experimental Eye Research. 88: 151-64. PMID 18773892 DOI: 10.1016/J.Exer.2008.08.002  0.597
2008 Danysh BP, Czymmek KJ, Olurin PT, Sivak JG, Duncan MK. Contributions of mouse genetic background and age on anterior lens capsule thickness. Anatomical Record (Hoboken, N.J. : 2007). 291: 1619-27. PMID 18951502 DOI: 10.1002/Ar.20753  0.537
Show low-probability matches.